29.90
0.08%
-0.0235
After Hours:
29.90
Simplify Health Care ETF stock is currently priced at $29.90, with a 24-hour trading volume of 20,333.
It has seen a -0.08% decreased in the last 24 hours and a +3.64% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $29.92 pivot point. If it approaches the $29.87 support level, significant changes may occur.
Previous Close:
$29.92
Open:
$29.76
24h Volume:
20,333
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.39%
1M Performance:
+3.64%
6M Performance:
+21.26%
1Y Performance:
+15.69%
Simplify Health Care ETF Stock (PINK) Company Profile
Name
Simplify Health Care ETF
Sector
Industry
Phone
614-469-3294
Address
-
Simplify Health Care ETF Stock (PINK) Latest News
AAR Corp. (NYSE:AIR) Sees Significant Growth in Short Interest - Defense World
Defense World
Wedbush Weighs in on Aerovate Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:AVTE) - Defense World
Defense World
Allogene Therapeutics, Inc. Forecasted to Post Q2 2024 Earnings of ($0.39) Per Share (NASDAQ:ALLO) - Defense World
Defense World
BriaCell Therapeutics (OTCMKTS:BCTXF) Trading Down 15.3% - Defense World
Defense World
Hudbay Minerals (TSE:HBM) Lifted to “Outperform” at National Bankshares - Defense World
Defense World
Analysts Issue Forecasts for BCE Inc.'s Q2 2024 Earnings (NYSE:BCE) - Defense World
Defense World
Simplify Health Care ETF Stock (PINK) Financials Data
There is no financial data for Simplify Health Care ETF (PINK). Check out other stocks for more information.
About Simplify Health Care ETF
Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 – 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
Cap:
|
Volume (24h):